SGMO Sangamo: Net Assets per Single Share

Official company branding of Sangamo Therapeutics (SGMO)

This daily price chart for Sangamo Therapeutics (SGMO) reflects the valuation of a business developing DNA technologies through global partnerships with pharma behemoths to achieve synergy in drug creation. The current indicator is -0.04. Sangamo Therapeutics (SGMO) relies on rare zinc-finger experts, maintaining a stable staff of researchers. The firm's innovations enable the correction of genetic glitches in the body, transforming a patient's code into a manageable treatment system for hereditary pathologies.

SGMO (Sangamo) Equity per Share history from 07/04/2022 to 05/09/2026

Summary analytical data breakdowns for sangamo.com (SGMO)

- current quotes and average value forecast:
Price Chart Sangamo|SGMO - Consensus Target
- company stock capitalization data:
Market Value Sangamo Therapeutics, Inc.|SGMO - Total Enterprise Value
- shareholders' equity book value data:
Book Value per Share Sangamo Therapeutics|SGMO - Accounting Capitalization|Market Value to Book Value Ratio sangamo.com|SGMO - Total Business Assets
- debt and liquidity details:
Total Debt to Capital Sangamo Therapeutics|SGMO - Long-Term Debt to Capital|Short-Term Debt to Equity Sangamo Therapeutics, Inc.|SGMO - Company Total Debt Obligations|Debts to Book Capitalization Sangamo Therapeutics, Inc.|SGMO - Company Long-Term Debts|Company Short-Term Debt Sangamo Therapeutics|Quick Ratio sangamo.com
- net income and valuation multiples indicators:
SGMO - Annual Net Income
Fundamental company analysis:Sangamo (SGMO)
Manufactured products of Sangamo Therapeutics, Inc.

Sangamo Therapeutics (SGMO) maintains its status as a leading innovator in gene editing, leveraging the deep trust of global pharmaceutical corporations. By analyzing the book value curve per share, an investor assesses capital stability through the ratio of operational growth to accounting write-downs, which helps determine the maturity of the business model and the risk of frozen funds in the absence of market demand for assets.

Competitors of Sangamo Therapeutics (SGMO)

TEM - Net Assets per Single Share|Qiagen Corp (QGEN) - Accounting Value per Share|Ionis Pharmaceuticals (IONS) - Net Assets per Single Share|Net Asset Value per Share repligen.com (RGEN)|RNA (Avidity Biosciences, Inc.) - Book Value per Share|Equity per Share CRSP (CRISPR Therapeutics Inc)|Net Assets per Single Share Sema4 (WGS)|Ultragenyx Corp - Equity per Share|Book Value per Share BEAM (Beam Therapeutics Inc.)|Book Value per Share sarepta.com SRPT|TWST - Net Assets per Single Share|Net Assets per Share 10x Genomics Inc TXG|NTLA: Book Value per Share|Stoke Corp (STOK) - Book Value per Share|Net Assets per Single Share BioLife Solutions, Inc.|Equity per Share WVE (wavelifesciences.com)|Book Value per Share MAZE|Sionna Therapeutics, Inc. (SION) - Book Value of One Share|Book Value per Share PRME (Prime Medicine Corp)|Book Value per Share Taysha Corp TSHA|QURE - Net Assets per Single Share|meiragtx.com (MGTX) - Accounting Value per Share|REGENXBIO (RGNX) - Net Assets per Single Share|Net Asset Value per Share Solid Biosciences Inc (SLDB)|Accounting Value per Share OCGN|PACB: Accounting Value of a Share|Accounting Value per Share BNTC (Benitec Biopharma Inc.)|Book Price of a Share DSGN|Book Value per Share RCKT (Rocket Pharmaceuticals, Inc.)|Accounting Value of a Share FDMT|Lexeo - Book Value per Share|Net Asset Value per Share Korro Bio, Inc.|Editas Medicine, Inc. (EDIT) - Net Assets per Single Share|silence-therapeutics.com - Accounting Value of a Share|PRQR (ProQR) - Book Value per Share|Book Value per Share Codexis Bio|Net Assets per Single Share Nautilus Biotechnology (NAUT)|MGX: Share Book Value|Book Value per Share DTIL (Precision BioSciences, Inc.)|Generation Bio Co (GBIO) - Net Asset Value per Share|BOLD: Accounting Value per Share|XCUR - Book Value per Share|IMNN (imunon.com) - Accounting Value per Share|PHIO: Book Price of a Share|MBIO (Mustang Bio Inc) - Book Value per Share|TransCode (RNAZ) - Net Assets per Share|Book Value per Share BNGO|Accounting Value per Share Applied DNA Sciences Inc APDN|Net Assets per Single Share Bluebird Bio BLUE|Net Assets per Share ImmunoPrecise Antibodies Ltd (IPA)|OMGA - Net Assets per Single Share|Net Assets per Share singulargenomics.com OMIC|RGLS: Book Value per Share|Book Value of One Share Syros Pharmaceuticals Inc. SYRS|Net Assets per Single Share Codex DNA|Accounting Value per Share TRACON Pharmaceuticals, Inc (TCON)|Net Assets per Single Share Unity Biotechnology (UBX)